These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 21548414)

  • 21. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How sudden is sudden cardiac death?
    Müller D; Agrawal R; Arntz HR
    Circulation; 2006 Sep; 114(11):1146-50. PubMed ID: 16952983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristic and clinical course of aborted sudden cardiac death patients with structurally normal heart in King Chulalongkorn Memorial Hospital.
    Thamaree S; Sunsaneewitayakul B
    J Med Assoc Thai; 2013 Mar; 96(3):272-9. PubMed ID: 23539928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden death in athletes: an update.
    Futterman LG; Myerburg R
    Sports Med; 1998 Nov; 26(5):335-50. PubMed ID: 9858396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nationwide (Denmark) study of symptoms preceding sudden death due to arrhythmogenic right ventricular cardiomyopathy.
    Sadjadieh G; Jabbari R; Risgaard B; Olesen MS; Haunsø S; Tfelt-Hansen J; Winkel BG
    Am J Cardiol; 2014 Apr; 113(7):1250-4. PubMed ID: 24513468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spectrum of epidemiology underlying sudden cardiac death.
    Hayashi M; Shimizu W; Albert CM
    Circ Res; 2015 Jun; 116(12):1887-906. PubMed ID: 26044246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sudden cardiac death and coronary disease in the young: A nationwide cohort study in Denmark.
    Zachariasardóttir S; Risgaard B; Ågesen FN; Jabbari R; Glinge C; Ingemann-Hansen O; Ottesen GL; Thomsen JL; Haunsø S; Banner J; Winkel BG; Tfelt-Hansen J
    Int J Cardiol; 2017 Jun; 236():16-22. PubMed ID: 28202258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis.
    Rattanawong P; Upala S; Riangwiwat T; Jaruvongvanich V; Sanguankeo A; Vutthikraivit W; Chung EH
    J Interv Card Electrophysiol; 2018 Mar; 51(2):91-104. PubMed ID: 29332241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in sudden death from coronary artery disease in young adults.
    Arzamendi D; Benito B; Tizon-Marcos H; Flores J; Tanguay JF; Ly H; Doucet S; Leduc L; Leung TK; Campuzano O; Iglesias A; Talajic M; Brugada R
    Am Heart J; 2011 Mar; 161(3):574-80. PubMed ID: 21392614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 2 diabetes and coronary artery disease: Preserved ejection fraction and sudden cardiac death.
    Junttila MJ; Kiviniemi AM; Lepojärvi ES; Tulppo M; Piira OP; Kenttä T; Perkiömäki JS; Ukkola OH; Myerburg RJ; Huikuri HV
    Heart Rhythm; 2018 Oct; 15(10):1450-1456. PubMed ID: 30274618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden cardiac death in 14- to 35-year olds in Ireland from 2005 to 2007: a retrospective registry.
    Margey R; Roy A; Tobin S; O'Keane CJ; McGorrian C; Morris V; Jennings S; Galvin J
    Europace; 2011 Oct; 13(10):1411-8. PubMed ID: 21798877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
    Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiologic assessment of surviving family members of young victims of sudden cardiac death: diagnostic yield].
    Autore C; Pagannone E; Re F; Romeo D; Musumeci B; Baratta P; Marino L; Cauti FM; Zachara E
    G Ital Cardiol (Rome); 2010; 11(7-8):557-65. PubMed ID: 21033332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.